50 related articles for article (PubMed ID: 21882634)
21. Distribution of the C-460T polymorphism of the vascular endothelial growth factor gene in age-related macular degeneration.
Szaflik JP; Błasiak J; Krzyanowska A; Zaraś M; Janik-Papis K; Borucka AI; Woźniak K; Szaflik J
Klin Oczna; 2009; 111(4-6):125-7. PubMed ID: 19673440
[TBL] [Abstract][Full Text] [Related]
22. Expression of vasohibin, an antiangiogenic factor, in human choroidal neovascular membranes.
Wakusawa R; Abe T; Sato H; Yoshida M; Kunikata H; Sato Y; Nishida K
Am J Ophthalmol; 2008 Aug; 146(2):235-243. PubMed ID: 18486097
[TBL] [Abstract][Full Text] [Related]
23. VEGF and age-related macular degeneration.
McKay GJ; Silvestri G; Orr N; Chakravarthy U; Hughes AE
Ophthalmology; 2009 Jun; 116(6):1227.e1-3. PubMed ID: 19486801
[No Abstract] [Full Text] [Related]
24. Annexin A2 promotes choroidal neovascularization by increasing vascular endothelial growth factor expression in a rat model of argon laser coagulation-induced choroidal neovascularization.
Zhao SH; Pan DY; Zhang Y; Wu JH; Liu X; Xu Y
Chin Med J (Engl); 2010 Mar; 123(6):713-21. PubMed ID: 20368092
[TBL] [Abstract][Full Text] [Related]
25. HTRA1 Overexpression Induces the Exudative Form of Age-related Macular Degeneration.
Iejima D; Nakayama M; Iwata T
J Stem Cells; 2015; 10(3):193-203. PubMed ID: 27125063
[TBL] [Abstract][Full Text] [Related]
26. Copy number variations in candidate genes in neovascular age-related macular degeneration.
Liu MM; Agrón E; Chew E; Meyerle C; Ferris FL; Chan CC; Tuo J
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3129-35. PubMed ID: 21273533
[TBL] [Abstract][Full Text] [Related]
27. [Age-related macular degeneration].
Budzinskaia MV
Vestn Oftalmol; 2014; 130(6):56-60. PubMed ID: 25715554
[TBL] [Abstract][Full Text] [Related]
28. [Pharmacogenetics and age-related macular degeneration, towards an individualized treatment of the disease].
Cruz-González F; Cabrillo Estévez L; López-Valverde G; Escudero-Domínguez F; González-Sarmiento R
Arch Soc Esp Oftalmol; 2013 Oct; 88(10):371-2. PubMed ID: 24060299
[No Abstract] [Full Text] [Related]
29. Myopic choroidal neovascularization genetics.
Fernandez-Robredo P; Maestre SR; Zarranz-Ventura J; Mulero HH; Salinas-Alaman A; Garcia-Layana A
Ophthalmology; 2008 Sep; 115(9):1632, 1632.e1. PubMed ID: 18762075
[No Abstract] [Full Text] [Related]
30. Genotype at polymorphism rs11200638 and HTRA1 expression level.
Wang G; Scott WK; Haines JL; Pericak-Vance MA
Arch Ophthalmol; 2010 Nov; 128(11):1491-3. PubMed ID: 21060055
[No Abstract] [Full Text] [Related]
31. [The genetic factors of non-response to anti-vascular endothelial growth factor therapy].
Xu SX; Huang SW; Su GF
Zhonghua Yan Ke Za Zhi; 2018 Nov; 54(11):873-878. PubMed ID: 30440160
[TBL] [Abstract][Full Text] [Related]
32. Focus on molecules: HtrA1 and neovascular AMD.
Jacobo SM; Kazlauskas A
Exp Eye Res; 2012 Jan; 94(1):4-5. PubMed ID: 20643126
[No Abstract] [Full Text] [Related]
33. A functional approach to examine the role of HTRA1 versus ARMS2 in AMD.
Fu Y
Invest Ophthalmol Vis Sci; 2014 Oct; 55(10):6524. PubMed ID: 25324346
[No Abstract] [Full Text] [Related]
34. Postnatal overexpression of the human ARMS2 gene does not induce abnormalities in retina and choroid in transgenic mouse models.
Liu J; Hoh J
Invest Ophthalmol Vis Sci; 2015 Feb; 56(2):1387-8. PubMed ID: 25717153
[No Abstract] [Full Text] [Related]
35. Author Response: Postnatal Overexpression of the Human ARMS2 Gene Does Not Induce Abnormalities in Retina and Choroid in Transgenic Mouse Models.
Iwata T
Invest Ophthalmol Vis Sci; 2015 Feb; 56(2):1389. PubMed ID: 25717154
[No Abstract] [Full Text] [Related]
36. [Influence of genetic mutations on clinical presentation of subretinal neovascularization. Report 2: The impact of HTRA and VEGF genes polymorphism].
Budzinskaia MV; Pogoda TV; Strelkova ID; Chikun EA; Shchegoleva IV; Kazarian ÉÉ; Galoian NS
Vestn Oftalmol; 2011; 127(4):9-16. PubMed ID: 21882634
[TBL] [Abstract][Full Text] [Related]
37. [Influence of genetic mutations on clinical presentation of subretinal neovascularization. Report 1: The impact of CFH and IL-8 genes polymorphism].
Budzinskaia MV; Pogoda TV; Generozov ÉV; Chikun EA; Shchegoleva IV; Kazarian ÉÉ; Galoian NS
Vestn Oftalmol; 2011; 127(4):3-8. PubMed ID: 21882633
[TBL] [Abstract][Full Text] [Related]
38. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization.
Tong JP; Chan WM; Liu DT; Lai TY; Choy KW; Pang CP; Lam DS
Am J Ophthalmol; 2006 Mar; 141(3):456-62. PubMed ID: 16490490
[TBL] [Abstract][Full Text] [Related]
39. Genotype-phenotype correlations for exudative age-related macular degeneration associated with homozygous HTRA1 and CFH genotypes.
Leveziel N; Zerbib J; Richard F; Querques G; Morineau G; Fremeaux-Bacchi V; Coscas G; Soubrane G; Benlian P; Souied EH
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3090-4. PubMed ID: 18362109
[TBL] [Abstract][Full Text] [Related]
40. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss.
Francis PJ; Hamon SC; Ott J; Weleber RG; Klein ML
J Med Genet; 2009 May; 46(5):300-7. PubMed ID: 19015224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
